InMed Pharmaceuticals (INM) has released an update.
InMed Pharmaceuticals Inc. is set to present at the Emerging Growth Conference on June 13, 2024, where CEO Eric A. Adams will discuss the company’s advancements and engage in a Q&A session. The conference will allow InMed, a clinical stage pharmaceutical company with a focus on small molecule drug candidates for various treatments, to showcase its developments to potential investors and analysts. A recording of the presentation will be available online for those unable to attend live.
For further insights into INM stock, check out TipRanks’ Stock Analysis page.
